Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Hydrochloric Acid → tert-butyl (3S,4R)-4-amino-3-fluoropiperidine-1-carboxylate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Hydrochloric Acid | HCID 313 | — |
| 반응물 | cis-4-Benzylamino-1-tert-butoxycarbonyl-3-fluoropiperidine | HCID 11312869 | — |
| 촉매 | Palladium | HCID 23938 | — |
| 용매 | Ethanol | HCID 702 | — |
| 생성물 | tert-butyl (3S,4R)-4-amino-3-fluoropiperidine-1-carboxylate | HCID 11736104 | 53% |
반응 단계
To a solution of the enantiomeric mixture of cis-4-benzylamino-1-tert-butoxycarbonyl-3-fluoropiperidine (prepared according to the procedures of J. Med. Chem. 1999, 42, 2087-2104, 1.0 g, 3.2 mmole) in EtOH (40 mL) was added 3 N HCl (2.5 L) and 10% Pd/C (50 mg). The reaction was shaken under H2 (40 psi) on a Parr apparatus for 14 h, then was filtered through Celite®. The filtrate was concentrated under reduced pressure, and the residue was purified by flash chromatography on silica gel (10% MeOH/CHCl3) to afford the title compound (370 mg, 53%) as a white solid.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07498326B2 |
| 출처 데이터셋 | uspto-grants-2009_03 |
| ORD ID | ord-22eb2861c23d43d680bdd14f2f88c5d2 |
| 출처 메모 | uspto-grants-2009_03 |